| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.006 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |